Selarsdi, a biosimilar to Stelara, is approved for adult and pediatric psoriatic arthritis, plaque psoriasis, Crohn disease, ...

The 470,000-square-foot facility will support the launch and commercial production of next-generation biologics and therapies ...

Sanofi announced an expansion of its partnership with McLaren Racing. The two companies, alongside United Autosports, are ...

AbbVie secures FDA approval for Rinvoq as the first oral Janus kinase inhibitor indicated for giant cell arteritis, expanding ...

RO is a DTP telehealth company that provides nationwide services. The company offers multiple GLP-1 options and has hired a ...

After announcing successful trial results for its lead mRNA treatment earlier this year, Regulus Therapeutics agreed to be ...

The Zensights Federated Healthcare Advisory Panel explores how shifting global dynamics are reshaping access and strategic ...

Sheeran continues the conversation on the collaboration between AWS and EVERSANA in the second part of this interview.

Capan discusses the collaboration between AWS and EVERSANA in the first part of this two-part interview.

A panel of experts examines how stakeholders can support strategies that improve patient outcomes, while also navigating ...

Will Pih, co-founder, Two Labs, explains how specialty pharmacies and manufacturers are adapting to financial pressures in rare disease care through patient-centric services, hub innovation, and ...